Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine Coadministered With Two Attenuated Vaccines
Conditions: SARS-CoV-2 Infection; Varicella; Measles; Mumps; Rubella Interventions: Biological: Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine; Biological: Inactivated SARS-CoV-2 vaccine coadministered with MMR; Biological: Inactivated SARS-CoV-2 vaccine administered alone Sponsors: Shanghai Municipal Center for Disease Control and Prevention; China National Biotec Group Company Limited Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Centers for Disease Control and Prevention (CDC) | Measles | Measles Vaccine | Mumps | Mumps Vaccine | Research | Rubella | Rubella Vaccine | SARS | Vaccines